Debbie Rigby takes a look at the latest news in research Hormonal contraception and mood disorders Hormonal contraception is known to precipitate or perpetuate depression in some patients. The link …

Debbie Rigby takes a look at the latest in research news Cannabis-Based Products for Chronic Pain A systematic review of 18 RCTs and 7 cohort studies has concluded that oral …

Debbie Rigby rounds up the latest in research news Short-acting β2-agonist prescriptions associated with poor clinical outcomes of asthma Use of three or more SABA canisters over 12 months was …

Debbie Rigby rounds up the latest in research news Dual bronchodilation for the treatment of COPD Dual bronchodilation with long-acting muscarinic receptor antagonists (LAMAs) and long-acting β-agonists (LABAs) fixed dose …

Debbie Rigby takes a look at the latest in research news Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities Pharmacist-led interventions in …

Debbie Rigby takes a look at the latest in research news Risk of first ischaemic stroke and use of antidopaminergic antiemetics Using French reimbursement data, researchers have shown an association …

Debbie Rigby rounds up the latest in research news Common conditions that mimic asthma Asthma is one of the most common chronic diseases in Australia, affecting 11% of the population. …

Debbie Rigby rounds up the latest in research news Inhaled corticosteroids: not just for asthma, but for COVID-19? Inhaled budesonide might be beneficial in some cases of early COVID-19 when …

Debbie Rigby rounds up the latest in research news A systematic review of opioid prevalence in Australian residential aged care facilities A systematic review on 23 studies on opioid prevalence …

Debbie Rigby outlines the latest research news and developments Antidepressants in adolescence In adolescence, antidepressants are second-line treatment options after psychological therapy for anxiety and obsessive compulsive disorder. A concern …

Debbie Rigby takes a look at the latest in research news Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum? Multiple therapeutic options for COVID-19 are …

Debbie Rigby rounds up the latest in research news Risks and burdens of incident diabetes in long COVID A large US cohort study has found a 40% increased risk of …